Home > Financial Ratios > SURAKSHA DIAGNOSTIC

SURAKSHA DIAGNOSTIC
Core EBITDA Margin

    Back to All Ratios
SURAKSHA DIAGNOSTIC is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SURAKSHA DIAGNOSTIC
Please provide your vote to see the results

SURAKSHA DIAGNOSTIC Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 30.9832.5032.4123.3721.54

What is the latest Core EBITDA Margin ratio of SURAKSHA DIAGNOSTIC ?

The latest Core EBITDA Margin ratio of SURAKSHA DIAGNOSTIC is 30.98 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar202630.98
Mar202532.50
Mar202432.41
Mar202323.37
Mar202221.54

How is Core EBITDA Margin of SURAKSHA DIAGNOSTIC Trending?

Years Core EBITDA Margin % Change
Mar2026 30.98
-4.68
Mar2025 32.5
0.28
Mar2024 32.41
38.68
Mar2023 23.37
8.50
Mar2022 21.54 -

Other Financial Ratios of SURAKSHA DIAGNOSTIC


Compare Core EBITDA Margin ratio of peers of SURAKSHA DIAGNOSTIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SURAKSHA DIAGNOSTIC ₹1,839.4 Cr 8% 8.3% 6.8% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹130,272.0 Cr 2% 2.6% 13.9% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹102,446.0 Cr 2.6% 6.2% -8.1% Stock Analytics
FORTIS HEALTHCARE ₹67,266.8 Cr 3% -1% -7.3% Stock Analytics
ASTER DM HEALTHCARE ₹66,295.0 Cr 1.4% -1.3% 22.1% Stock Analytics
NARAYANA HRUDAYALAYA ₹39,270.0 Cr 1.7% 3.7% 6.2% Stock Analytics


SURAKSHA DIAGNOSTIC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SURAKSHA DIAGNOSTIC

8%

8.3%

6.8%

SENSEX

0.7%

-3.5%

-9.2%


You may also like the below Video Courses